Learning is a key to... • 10h
R&D Spend of Pharma Stocks – Q3FY26 Innovation drives growth in the pharmaceutical sector. Here are some prominent pharma companies investing heavily in Research & Development this quarter: 🔹 Sun Pharma – ₹892 Cr (5.8%) 🔹 Zydus Lifesciences – ₹604 Cr (8.8%) 🔹 Lupin – ₹535 Cr (7.5%) 🔹 Cipla – ₹494 Cr (7.0%) 🔹 Aurobindo Pharma – ₹409 Cr (4.7%) 🔹 Gland Pharma – ₹65 Cr (5.4%) 📌 Companies with higher R&D investment often focus on long-term innovation, pipeline strength, and global expansion. 💬 Which pharma stock do you track closely?

The Way I See It • 5m
India loves growth. But hates research. We celebrate valuations, unicorns, and market size. But when it comes to putting money into research & development, we’re still miles behind. 📊 The reality check: 🇮🇳 India → 0.6–0.7% of GDP on R&D 🇯🇵 Jap
See More•
Faad Network • 10m
India can’t beat China. Let us talk numbers. China has 200 lakh CR tax revenue (5 times more than us) China has 2.2 million R&D workers (2.5 times more than us) China's R&D budget was 420,000 CR last year (21 times more than us) China slashed 361
See MoreStay updated with th... • 8m
Oben Electric Raises ₹100 Cr in Series A Round to Expand Affordable EVs Nationwide Bengaluru-based EV startup Oben Electric has secured ₹100 Cr in Series A funding, with an additional ₹50 Cr in extended Series A, bringing its total raise to ₹200 Cr.
See More

Believe me, it’s not... • 7m
If you’ve ever bought a door lock (esp. in Maharashtra), chances are it came from 'Europa Locks'(a.k.a Welmade Locking Systems). Started in 1984 → Dr. P.A. Joshi (ex-Godrej, German-trained) launched Europa Locks, one of India's earliest 'anti-theft
See MoreDownload the medial app to read full posts, comements and news.